HR 124
119th Congress
House
Health
Cancer
Digestive and metabolic diseases
Health promotion and preventive care
Medicaid
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 3, 2025
Referred to the House Committee on Energy and Commerce.
Jan 3, 2025
Introduced in House
Plain-English summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]
This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1